About
Developer of the Eagle direct SLT laser for glaucoma. Acquired by Alcon (2025), $81M upfront.
HQ: Israel
Funding
Acquired by Alcon (2025)
—Company profile
Eagle DSLT — direct selective laser trabeculoplasty, a non-invasive glaucoma treatment acquired by Alcon.
Developer of the Eagle direct SLT laser for glaucoma. Acquired by Alcon (2025), $81M upfront.
HQ: Israel